CG Oncology (CGON) Leases (2023 - 2026)

CG Oncology posted quarterly Leases of $4.5 million for Q1 2026, up 336.79% year-on-year from $1.0 million in Q1 2025, and up 13.62% on a QoQ basis from $4.0 million in Q4 2025.

CG Oncology (CGON) has 4 years of Leases data on file, last reported at $4.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Leases rose 336.79% year-over-year to $4.5 million; the trailing twelve-month figure through Mar 2026 stood at $4.5 million (up 336.79% YoY), and the FY2025 full-year result was $4.0 million, up 1696.83% from the prior year.
  • Leases for Q1 2026 stood at $4.5 million, up from $4.0 million in the prior quarter.
  • Across five years, Leases topped out at $4.5 million in Q1 2026 and bottomed at $221000.0 in Q4 2024.
  • The 4-year median for Leases is $693500.0 (2023), against an average of $1.6 million.
  • The widest annual swing landed in 2024, when Leases tumbled 47.63%; it then surged 1696.83% in 2025.
  • A 4-year view of Leases shows it stood at $422000.0 in 2023, then sank by 47.63% to $221000.0 in 2024, then soared by 1696.83% to $4.0 million in 2025, then rose by 13.62% to $4.5 million in 2026.
  • The last three Leases figures came in at $4.5 million (Q1 2026), $4.0 million (Q4 2025), and $4.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 61,822.50
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 189.30 Mn
10 CG Oncology 5.01 Bn 5.01 Bn -1.88 Mn 4.51 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.51 Mn
Dec 31, 2025 3.97 Mn
Sep 30, 2025 4.20 Mn
Jun 30, 2025 965,000.00
Mar 31, 2025 1.03 Mn
Dec 31, 2024 221,000.00
Sep 30, 2024 275,000.00
Jun 30, 2024 329,000.00
Mar 31, 2024 368,000.00
Dec 31, 2023 422,000.00